• contact us navContact Us
  • search navSearch
Let's connect

Want to discuss your project or have any questions?

Consultancy services 

DMPK consultancy for drug discovery and development  

We guide our clients through all phases of the R&D value chain, from early drug discovery and investigational new drug (IND) progression to clinical development. We also support scientific writing for regulatory documents required for marketing authorisation. Our extensive experience in supporting multidisciplinary drug discovery and development teams in the pharmaceutical industry allows us to integrate seamlessly into your project team or operate as a standalone function. We provide our services to academia, CROs, biotechnological and pharmaceutical companies, and life science venture capital funds.

Scientists discussing a graph in a meeting room

Experienced, expert DMPK consultancy and guidance

Our service portfolio includes PK consultancy, gap analyses, and drug metabolism and pharmacokinetics (DMPK) data assessments (e.g., for due diligence), project management with DMPK representation in project teams, support for candidate selection, and the generation of tailor-made drug development plans. We also offer scientific writing services, including study reports and DMPK sections of IND (Investigational New Drug), IMPD (Investigational Medicinal Product Dossier), IB (Investigator's Brochure) or briefing books. Our DMPK experts inform the design of clinical trials by predicting the human pharmacokinetics of your drug candidate using allometric scaling and other methodologies. They estimate efficacious doses based on pre-defined exposure targets and evaluate in vitro drug–drug interactions (DDI) using basic and mechanistic static modelling. This helps ensure appropriate starting doses and concomitant medications for your trials.  

 
v.1.1.1203